Peter Bruce McIntyre

Professor McIntyre’s clinical background is in paediatric infectious diseases and he has a specialist appointment at the Children’s Hospital, Westmead. The subject of Professor McIntyre’s PhD was the epidemiology and vaccine prevention of invasive Haemophilus influenzae type b (Hib) disease. He became Director of the National Centre for Immunisation Research and Surveillance of Vaccine-Preventable Diseases in 2004 and also sits on the Australian Technical Advisory Group on Immunisation, the Communicable Diseases Network of Australia and the National Immunisation Committee.

Professor McIntyre has been a member of working groups for the World Health Organisation’s Strategic Advisory Group of Experts in pneumococcal disease and pertussis and of the pertussis working group of the United States Advisory Committee on Immunisation Practice. He was recently appointed to the WHO’s advisory committee on Immunisation Research.

He has over 150 publications covering a wide range of topics in vaccine-preventable diseases.

Professor McIntyre’s research interests are broadly in the area of the epidemiology of vaccine-preventable diseases (VPDs), including measurement of disease burden pre vaccine introduction, measurement of immunisation coverage and measurement of the impact of vaccines post introduction. He has a strong record in clinical vaccine trials and is currently the Chief Investigator for a multi-site national vaccine trial looking at giving pertussis vaccine to newborns. His major special interests are in bacterial VPDs, including Haemophilus influenzae type b, pneumococcus and pertussis.